Access comprehensive financial analyses and make smarter investments - get the Manual of Investments on Amazon!

IVZ

Invesco Reports $25.6B in Q4 Inflows

Invesco Ltd. (NYSE: IVZ) has released its financial results for the fourth quarter and full year ending December 31, 2024. The company reported net long-term inflows of $25.6 billion for the quarter, primarily driven by ETFs and APAC managed assets. For the full year 2024, net long-term inflows amounted to $65.1 billion, with significant contributions from ETFs, APAC managed, fundamental fixed income, and private markets.

The ending assets under management (AUM) stood at $1.85 trillion, marking a 2.8% increase from the prior quarter and a substantial 16.4% increase from the previous year-end. Notably, the operating margin for Q4 2024 reached 19.6%, while the adjusted operating margin was 33.7%.

In terms of capital management, Invesco maintained a zero balance on its credit facility and held cash and cash equivalents of $1 billion. During the quarter, the company repurchased 1.4 million common shares for $25 million.

Looking at the financial highlights, the U.S. GAAP diluted EPS for the fourth quarter was reported at $0.46, with adjusted diluted EPS at $0.52, representing an increase of 18.2% from the previous quarter. Net revenues for Q4 2024 were $1,157.2 million, reflecting a 4.8% increase from the prior quarter.

Comparing the fourth quarter of 2024 to the same period in 2023, operating revenues increased by $179.6 million, while adjusted operating income rose by 114.7 million, resulting in an adjusted operating margin of 33.7%, a significant improvement from the 26.3% margin in Q4 2023.

As a result of these announcements, the company's shares have moved 9.2% on the market, and are now trading at a price of $19.38. For more information, read the company's full 8-K submission here.

The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.

IN FOCUS